Affinity capture and elution/electrospray ionization mass spectrometry assay of phosphomannomutase and phosphomannose isomerase for the multiplex analysis of congenital disorders of glycosylation types Ia and Ib.
Affinity capture and elution/electrospray ionization mass spectrometry assay of phosphomannomutase and phosphomannose isomerase for the multiplex analysis of congenital disorders of glycosylation types Ia and Ib.
复制标题
磷酸甘露糖变位酶和磷酸甘露糖异构酶的亲和捕获和洗脱/电喷雾电离质谱测定,用于糖基化类型 Ia 和 Ib 先天性疾病的多重分析。
DOI:
10.1021/ac0205053
复制
发表时间:
2003
影响因子:
7.4
通讯作者:
Gelb,MichaelH
中科院分区:
文献类型:
--
作者:
Li,Yijun;Ogata,Yuko;Freeze,HudsonH;Scott,CRonald;Turecek,Frantisek;Gelb,MichaelH
We report a new application of affinity capture-elution electrospray mass spectrometry (ACESI-MS) to assay the enzymes phosphomannomutase (PMM) and phosphomannose isomerase (PMI), which when deficient cause congenital disorders of glycosylation CDG-type Ia and type Ib, respectively. The novel feature of this mass-spectrometry-based assay is that it allows one to distinguish and quantify enzymatic products that are isomeric with their substrates that are present simultaneously in complex mixtures, such as cultured human cell homogenates. This is achieved by coupled assays in which the PMM and PMI primary products are in vitro subjected to another enzymatic reaction with yeast transketolase that changes the mass of the products to be detected by mass spectrometry. The affinity purification procedure is fully automated, and the mass spectrometric analysis is multiplexed in a fashion that is suitable for high-throughput applications.